Leading portfolio executives are sharing perspectives on risk measurement, data integrity and governance, and maximizing R&D budget for new discoveries.
Hovione is present at the 2nd Annual Pharmaceutical Portfolio Strategy & Management Conference in Philadelphia with a participation in a panel discussion.
Speaker: Steven Krivicich, Program & Portfolio Director at Hovione
Topics in discussion
If you are attending this conference and would like to chat with us about your projects, schedule a meeting with us. Our colleagues will be pleased to meet you.
Hovione, the leader in spray drying and particle engineering, announced today an exclusive license agreement for a preclinical ophthalmology program, JX08, with Ji Xing Pharmaceuticals Limited (JIXING).
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Hovione, the leader in spray drying and particle engineering, announced today a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.